Finance

Chartstopper: October 9, 2026

Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard

Nasdaq CEO Flags Tens of Billions in New Wall Street Opportunity

Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up